Quick answers
- What is Plegridy Pen?
- Plegridy Pen is a brand name of Peginterferon BETA-1A, a prescription medicine. The FDA NDC Directory lists 1 Plegridy Pen product in 1 strength and form.
- Who makes Plegridy Pen?
- Biogen Idec Inc holds the FDA application for Plegridy Pen (BLA125499, approved August 15, 2014).
- Is there a generic or store brand of Plegridy Pen?
- Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Plegridy Pen product. Ask your pharmacist whether one is right for you.
- Has Plegridy Pen been recalled?
- No recall linked to Plegridy Pen products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Plegridy Pen is
Each Plegridy Pen product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Peginterferon BETA-1A · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| peginterferon BETA-1A 125 ug/0.5 mL injection, solution (subcutaneous) | Plegridy Pen | 2 products, 1 company | — |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Peginterferon BETA-1A →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA125499 | Biogen Idec Inc | August 15, 2014 | 1 |
Companies that list Plegridy Pen
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Plegridy Pen products.
- Biogen Inc.1 product
Recalls
No recall linked to Plegridy Pen products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.